Blood test to predict vitiligo activity and outlook
Part of Skin clinical trials.
This study is looking at whether levels of certain immune proteins (called cytokines) in your blood can help predict how vitiligo will progress. By participating, you help doctors develop a tool to better plan treatment and understand your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are able to understand and complete study instructions (elementary school education or higher)
- You have been diagnosed with vitiligo (patients) or you are a healthy volunteer
- You have not taken antibiotics, steroids, or immune-suppressing drugs in the past month
- You do not have severe heart, brain, blood, or autoimmune diseases, and you are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This study looks at differences in the gut and skin microbiome (the germs living in and on the body) in people with vitiligo and in people without vitiligo. It aims to understand what might be linked to how vitiligo spreads over time.
This study looks at how vitiligo affects your daily life, work, and overall well-being. By answering a few questionnaires, you help researchers understand the real impact of vitiligo, which could lead to better support and treatments.
This study tests a new medicine called LY4005130 for non-segmental vitiligo, a skin condition where patches lose pigment (color). The trial aims to see if this drug can help restore skin color and stop the spread of white patches.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.